Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

31 Aug 2026 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated August 31, 2026, titled ‘Zydus Announces Positive Topline Results from Completed EVIDENCES-X Phase II(b) Clinical Trial of Saroglitazar Mg in MASH’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1878.95
Dr. Reddys Labs. 1384.70
Cipla 1406.50
Lupin 2016.55
Zydus Lifesciences 1198.55
View more..